SAN JOSE, Calif.--(BUSINESS WIRE)--Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, launched officially today and announced availability of its non-invasive, wireless system to monitor cardiac health. Corventis’ inaugural product, the AVIVO™ Mobile Patient Management System, has received U.S. Food and Drug Administration (FDA) clearance and is now commercially available for use by clinicians within and outside the United States.
